Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Hematological toxicity in patients with solid malignant tumors treated with radiation - temporal analysis, dose response and impact on survival

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Response to Aviv et al

    Research output: Contribution to journalLetterpeer-review

  3. The risk of late effects following pediatric and adult radiotherapy regimens in Hodgkin lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: To describe the kinetics of the peripheral blood components after radiotherapy, to examine radiation exposure vs. End-of-Radiation-Therapy (EoRT) counts and to associate the EoRT lymphocyte count with death and cancer treatment failure.

MATERIALS AND METHODS: Cohort study of patients who received curative intent radiotherapy for solid tumor diagnoses from 2009-2016 at Rigshospitalet, Copenhagen and had available 3D radiation exposure data. We illustrated peripheral blood count kinetics within 12 months before and after radiotherapy start and analyzed the impact of the irradiated body volume. We investigated overall survival and cancer treatment failure according to EoRT lymphopenia using Cox regression analyses.

RESULTS: We analyzed 4055 patients with both pre-treatment and EoRT platelet counts and 2318 patients who also had neutrophil and lymphocyte counts. Only the lymphocyte decline after radiotherapy start was clinically relevant and remained low one year after radiotherapy. The higher the volume of the body exposed to radiation, the lower the EoRT blood counts. Female gender (p<0.001), number of fractions (p=0.010), dose-volume (p<0.001) and concomitant use of chemotherapy, particularly the platinum compounds (p<0.001) were independently associated with a lower EoRT lymphocyte count. Patients with head and neck cancer had the lowest EoRT lymphocyte count. Patients with lymphopenia had a higher risk of death in the year after radiotherapy, compared with patients with no lymphopenia.

CONCLUSION: Radiation schemes with fewer fractions and radiation techniques allowing reduction of the volume of the body exposed to radiation could be expected to better preserve patients' immune function.

Original languageEnglish
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Volume158
Pages (from-to)175-183
Number of pages9
ISSN0167-8140
DOIs
Publication statusPublished - May 2021

    Research areas

  • Dose response, Dose-volume, Hematological toxicity, Radiation-induced lymphopenia, Survival

ID: 64030968